Evidence map›Paper›PMID 31561543›Full record

ArticleMaterials (Basel, Switzerland)2019

Synthesis of Poly(3-vinylpyridine)-

Katharina Nieswandt, Prokopios Georgopanos, Clarissa Abetz, Volkan Filiz, Volker Abetz

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Katharina NieswandtHelmholtz-Zentrum Geesthacht, Institute of Polymer Research, Max-Planck-Straße 1, 21502 Geesthacht, Germany. katharina.nieswandt@hzg.de.ORCID 0000-0001-7454-1908
Prokopios GeorgopanosHelmholtz-Zentrum Geesthacht, Institute of Polymer Research, Max-Planck-Straße 1, 21502 Geesthacht, Germany. prokopios.georgopanos@hzg.de.ORCID 0000-0002-6394-0628
Clarissa AbetzHelmholtz-Zentrum Geesthacht, Institute of Polymer Research, Max-Planck-Straße 1, 21502 Geesthacht, Germany. clarissa.abetz@hzg.de.ORCID 0000-0001-6845-0145
Volkan FilizHelmholtz-Zentrum Geesthacht, Institute of Polymer Research, Max-Planck-Straße 1, 21502 Geesthacht, Germany. volkan.filiz@hzg.de.ORCID 0000-0003-0239-8641
Volker AbetzHelmholtz-Zentrum Geesthacht, Institute of Polymer Research, Max-Planck-Straße 1, 21502 Geesthacht, Germany. volker.abetz@hzg.de.ORCID 0000-0002-4840-6611
Helmholtz-Zentrum Hereon · DEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, we present a novel synthetic route to diblock copolymers based on styrene and 3-vinylpyridine monomers. Surfactant-free water-based reversible addition-fragmentation chain transfer (RAFT) emulsion polymerization of styrene in the presence of the macroRAFT agent poly(3-vinylpyridine) (P3VP) is used to synthesize diblock copolymers with molecular weights of around 60 kDa. The proposed mechanism for the poly(3-vinylpyridine)-

Indexed as

poly(3-vinylpyridine), amphiphilic block copolymerpolymerization-induced self-assembly (PISA), surfactant-free RAFT emulsion polymerizationRAFT polymerization

Identifiers

PMID31561543
PMCPMC6803976
OpenAlexW2976687718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.